Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular DiseasePhilip C. Robinson, Mark Nidorf, Vangelis Karalis et al.|The American Journal of Medicine|2021Cited by 122
Colchicine for the treatment of COVID-19 patients: efficacy, safety, and model informed dosage regimensEleni Karatza, Vangelis Karalis, George Ismailos|Xenobiotica|2021Cited by 38
Chloroquine dosage regimens in patients with COVID-19: Safety risks and optimization using simulationsVangelis Karalis, Eleni Karatza, George Ismailos|Safety Science|2020Cited by 28